Cost-Utility Analysis of Non-Invasive Tests to Initiate Hepatocellular Carcinoma Surveillance in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Decharatanachart P. et al, (2025), Am J Gastroenterol
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak P. et al, (2024), The Lancet Infectious Diseases, 24, 953 - 963
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults.
Hanboonkunupakarn B. et al, (2024), NPJ vaccines, 9
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update.
Cooke GS. et al, (2024), The lancet. Gastroenterology & hepatology, 9, 346 - 365
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
Pukrittayakamee S. et al, (2024), eLife, 12
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Luvira V. et al, (2024), BMC Infectious Diseases, 24
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Schilling WHK. et al, (2024), The Lancet Infectious Diseases, 24, 36 - 45
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Jittamala P. et al, (2023), The Journal of Infectious Diseases, 228, 1318 - 1325
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling WHK. et al, (2023), eLife, 12
Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry.
Chirapongsathorn S. et al, (2023), Journal of clinical and translational hepatology, 11, 88 - 96
Severity of COVID-19 in Patients with Diarrhoea: A Systematic Review and Meta-Analysis.
Dhakal S. et al, (2023), Tropical medicine and infectious disease, 8
Regional Differences in Admissions and Treatment Outcomes for Hepatocellular Carcinoma Patients in Thailand.
Kitiyakara T. et al, (2022), Asian Pacific journal of cancer prevention : APJCP, 23, 3701 - 3715
Prevalence, Risk Factors, and Prognosis of Liver Involvement in Adult Patients with Chikungunya in Thailand.
Srikirin P. et al, (2022), The American journal of tropical medicine and hygiene
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B.
Yuen M-F. et al, (2022), Hepatology communications
Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B.
Limothai U. et al, (2022), Asian Pacific journal of allergy and immunology, 40, 87 - 93
Health care burden and mortality of acute on chronic liver failure in Thailand: a nationwide population-based cohort study.
Chirapongsathorn S. et al, (2022), BMC health services research, 22
Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies.
Sriboonvorakul N. et al, (2021), Journal of clinical medicine, 10
Assessment of the amino acid profile in Thai patients with type 2 diabetes mellitus using liquid chromatography-mass spectrometry
Sriboonvorakul N. et al, (2021), International Health, 13, 367 - 373